Participants 59 80 5
severe bronchiectasis
Participants 423 603 7
Twenty-four patients (12 female; mean age 51 yr) were randomized into receiving either inhaled fluticasone (500 microgram twice daily) via the Accuhaler device (n = 12) or placebo.
